The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(1-(6-((2-(dimethylamino)benzyl)(ethyl)amino)hexyl)-6-oxo-1,6-dihydropyridazin-3-yl)-4-hydroxyphenyl)acetamide ID: ALA5179810
Chembl Id: CHEMBL5179810
PubChem CID: 168273802
Max Phase: Preclinical
Molecular Formula: C29H39N5O3
Molecular Weight: 505.66
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CCCCCCn1nc(-c2cc(NC(C)=O)ccc2O)ccc1=O)Cc1ccccc1N(C)C
Standard InChI: InChI=1S/C29H39N5O3/c1-5-33(21-23-12-8-9-13-27(23)32(3)4)18-10-6-7-11-19-34-29(37)17-15-26(31-34)25-20-24(30-22(2)35)14-16-28(25)36/h8-9,12-17,20,36H,5-7,10-11,18-19,21H2,1-4H3,(H,30,35)
Standard InChI Key: PNJAZXJXBGGURX-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 505.66Molecular Weight (Monoisotopic): 505.3053AlogP: 4.72#Rotatable Bonds: 13Polar Surface Area: 90.70Molecular Species: BASEHBA: 7HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.56CX Basic pKa: 9.47CX LogP: 3.22CX LogD: 2.27Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.26Np Likeness Score: -1.52
References 1. Shi Y, Zhang H, Song Q, Yu G, Liu Z, Zhong F, Tan Z, Liu X, Deng Y.. (2022) Development of novel 2-aminoalkyl-6-(2-hydroxyphenyl)pyridazin-3(2H)-one derivatives as balanced multifunctional agents against Alzheimer's disease., 230 [PMID:35026532 ] [10.1016/j.ejmech.2021.114098 ]